Baseline serum and cerebrospinal fluid magnesium levels in normal pregnancy and preeclampsia

Jill Fong, Edith D. Gurewitsch Allen, Lorraine Volpe, William E. Wagner, Matthew C. Gomillion, Phyllis August

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Objective: To determine whether baseline cerebrospinal fluid magnesium levels in preeclampsia differ from those in normal pregnancy, and to ascertain whether pre-treatment cerebrospinal fluid magnesium levels correlate with serum levels, which would suggest a baseline alteration in the blood-brain barrier in preeclampsia. Methods: When spinal analgesia or anesthesia was administered for delivery, serum and cerebrospinal fluid magnesium levels were determined in 20 normal gravidas and 20 preeclamptic women not treated with magnesium sulfate. Data were analyzed by two-sided Student t test and regression analysis. Results: Mean (± standard deviation) cerebrospinal fluid magnesium level for preeclamptic patients was 2.23 ± 0.09 mEq/L, which was not significantly different from controls. Regression analysis revealed no significant correlation between cerebrospinal fluid and serum magnesium levels for either normal or preeclamptic gravidas. Conclusion: During the third trimester, there is no difference in baseline, pre-treatment cerebrospinal fluid magnesium levels in preeclamptic patients compared to normal subjects, and no correlation between cerebrospinal fluid and serum magnesium over the range of baseline values.

Original languageEnglish (US)
Pages (from-to)444-448
Number of pages5
JournalObstetrics and Gynecology
Volume85
Issue number3
DOIs
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Pre-Eclampsia
Magnesium
Cerebrospinal Fluid
Pregnancy
Serum
Regression Analysis
Anesthesia and Analgesia
Magnesium Sulfate
Third Pregnancy Trimester
Blood-Brain Barrier
Students
Therapeutics

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Baseline serum and cerebrospinal fluid magnesium levels in normal pregnancy and preeclampsia. / Fong, Jill; Gurewitsch Allen, Edith D.; Volpe, Lorraine; Wagner, William E.; Gomillion, Matthew C.; August, Phyllis.

In: Obstetrics and Gynecology, Vol. 85, No. 3, 01.01.1995, p. 444-448.

Research output: Contribution to journalArticle

Fong, Jill ; Gurewitsch Allen, Edith D. ; Volpe, Lorraine ; Wagner, William E. ; Gomillion, Matthew C. ; August, Phyllis. / Baseline serum and cerebrospinal fluid magnesium levels in normal pregnancy and preeclampsia. In: Obstetrics and Gynecology. 1995 ; Vol. 85, No. 3. pp. 444-448.
@article{c49b0f74853b440aa2638af5cd1461d9,
title = "Baseline serum and cerebrospinal fluid magnesium levels in normal pregnancy and preeclampsia",
abstract = "Objective: To determine whether baseline cerebrospinal fluid magnesium levels in preeclampsia differ from those in normal pregnancy, and to ascertain whether pre-treatment cerebrospinal fluid magnesium levels correlate with serum levels, which would suggest a baseline alteration in the blood-brain barrier in preeclampsia. Methods: When spinal analgesia or anesthesia was administered for delivery, serum and cerebrospinal fluid magnesium levels were determined in 20 normal gravidas and 20 preeclamptic women not treated with magnesium sulfate. Data were analyzed by two-sided Student t test and regression analysis. Results: Mean (± standard deviation) cerebrospinal fluid magnesium level for preeclamptic patients was 2.23 ± 0.09 mEq/L, which was not significantly different from controls. Regression analysis revealed no significant correlation between cerebrospinal fluid and serum magnesium levels for either normal or preeclamptic gravidas. Conclusion: During the third trimester, there is no difference in baseline, pre-treatment cerebrospinal fluid magnesium levels in preeclamptic patients compared to normal subjects, and no correlation between cerebrospinal fluid and serum magnesium over the range of baseline values.",
author = "Jill Fong and {Gurewitsch Allen}, {Edith D.} and Lorraine Volpe and Wagner, {William E.} and Gomillion, {Matthew C.} and Phyllis August",
year = "1995",
month = "1",
day = "1",
doi = "10.1016/0029-7844(94)00413-8",
language = "English (US)",
volume = "85",
pages = "444--448",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Baseline serum and cerebrospinal fluid magnesium levels in normal pregnancy and preeclampsia

AU - Fong, Jill

AU - Gurewitsch Allen, Edith D.

AU - Volpe, Lorraine

AU - Wagner, William E.

AU - Gomillion, Matthew C.

AU - August, Phyllis

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Objective: To determine whether baseline cerebrospinal fluid magnesium levels in preeclampsia differ from those in normal pregnancy, and to ascertain whether pre-treatment cerebrospinal fluid magnesium levels correlate with serum levels, which would suggest a baseline alteration in the blood-brain barrier in preeclampsia. Methods: When spinal analgesia or anesthesia was administered for delivery, serum and cerebrospinal fluid magnesium levels were determined in 20 normal gravidas and 20 preeclamptic women not treated with magnesium sulfate. Data were analyzed by two-sided Student t test and regression analysis. Results: Mean (± standard deviation) cerebrospinal fluid magnesium level for preeclamptic patients was 2.23 ± 0.09 mEq/L, which was not significantly different from controls. Regression analysis revealed no significant correlation between cerebrospinal fluid and serum magnesium levels for either normal or preeclamptic gravidas. Conclusion: During the third trimester, there is no difference in baseline, pre-treatment cerebrospinal fluid magnesium levels in preeclamptic patients compared to normal subjects, and no correlation between cerebrospinal fluid and serum magnesium over the range of baseline values.

AB - Objective: To determine whether baseline cerebrospinal fluid magnesium levels in preeclampsia differ from those in normal pregnancy, and to ascertain whether pre-treatment cerebrospinal fluid magnesium levels correlate with serum levels, which would suggest a baseline alteration in the blood-brain barrier in preeclampsia. Methods: When spinal analgesia or anesthesia was administered for delivery, serum and cerebrospinal fluid magnesium levels were determined in 20 normal gravidas and 20 preeclamptic women not treated with magnesium sulfate. Data were analyzed by two-sided Student t test and regression analysis. Results: Mean (± standard deviation) cerebrospinal fluid magnesium level for preeclamptic patients was 2.23 ± 0.09 mEq/L, which was not significantly different from controls. Regression analysis revealed no significant correlation between cerebrospinal fluid and serum magnesium levels for either normal or preeclamptic gravidas. Conclusion: During the third trimester, there is no difference in baseline, pre-treatment cerebrospinal fluid magnesium levels in preeclamptic patients compared to normal subjects, and no correlation between cerebrospinal fluid and serum magnesium over the range of baseline values.

UR - http://www.scopus.com/inward/record.url?scp=0028800732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028800732&partnerID=8YFLogxK

U2 - 10.1016/0029-7844(94)00413-8

DO - 10.1016/0029-7844(94)00413-8

M3 - Article

C2 - 7862389

AN - SCOPUS:0028800732

VL - 85

SP - 444

EP - 448

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 3

ER -